Clinical Trial Update: Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of a vildagliptin and metformin combination in adults with type 2 diabetes not adequately controlled on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin/metformin combination (vildagliptin/metformin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED